This year, our list of NEJM Journal Watch Oncology and Hematology top stories includes studies on malignant and benign hematology as well as breast, prostate, lung, pancreatic, and skin cancers. These summaries underscore our goal of identifying the most clinically relevant studies and highlighting their key points, implications, and applications. We look forward to continuing to bring you concise summaries of the most important research in oncology and hematology during the coming year.
Our oncology and hematology top 10 stories of 2016 are as follows:
Targeted Therapy for Hairy Cell Leukemia
Chemotherapy-Free Induction for Mantle Cell Lymphoma
Chronic GVHD Partially Prevented by Antilymphocyte Globulin
Extending Aromatase Inhibitor Ther…
Author
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)